Adiponectin, diabetes and ischemic heart failure: A challenging relationship

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Baldasseroni, Samuele ^a,b   Antenore, Alessandro ^a,b   Di Serio, Claudia ^a,b   Orso, Francesco ^a,b   Lonetto, Giuseppe ^a,b   Bartoli, Nadia ^a,b   Foschini, Alice ^a,b   Marella, Andrea ^a,b   Pratesi, Alessandra ^a,b   Scarantino, Salvatore ^a,b   Fumagalli, Stefano ^a,b   Monami, Matteo ^a,b   Mannucci, Edoardo ^a,b   Marchionni, Niccolò ^a,b   Tarantini, Francesca ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adiponectin; Coronary artery disease; Diabetes; Heart failure

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HUMAN; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; REGULATORY MECHANISM;

ADIPONECTIN; AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 84871132740     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-151     Document Type: Article

References (34)

1. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrin Met 2000, 11:327-332.
2. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005, 288:H2031-H2041. 10.1152/ajpheart.01058.2004, 15653761.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83. 10.1006/bbrc.1999.0255, 10092513.
4. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792. 10.1172/JCI29126, 1483172, 16823476.
5. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295. 10.1038/nm788, 12368907.
6. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133. 10.2337/diabetes.50.5.1126, 11334417.
7. Tuttolomondo A, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo Sasso B, Guercio G, Diana G, Ciaccio M, Licata G, Pinto A. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol 2010, 9:50. 10.1186/1475-2840-9-50, 2946274, 20836881.
8. Jansson PA, Pellmé F, Hammarstedt A, Sandqvist M, Brekke H, Caidahl K, Forsberg M, Volkmann R, Carvalho E, Funahashi T, Matsuzawa Y, Wiklund O, Yang X, Taskinen MR, Smith U. A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J 2003, 17:1434-1440. 10.1096/fj.02-1132com, 12890697.
9. Han SH, Quon MJ, Kim J, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007, 49:531-538. 10.1016/j.jacc.2006.08.061, 17276175.
10. Barseghian A, Gawande D, Bajaj M. Adiponectin and vulnerable atherosclerotic plaques. J Am Coll Cardiol 2011, 57:761-770. 10.1016/j.jacc.2010.11.011, 21310310.
11. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006, 16:141-146. 10.1016/j.tcm.2006.03.001, 2749293, 16781946.
12. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, Grossman E, Sheps D, Keren G, Roth A. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006, 92:1420-1424. 10.1136/hrt.2005.083345, 1861042, 16621874.
13. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Saito M, Momomura S, Ishikawa SE. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 2006, 70:1557-1562. 10.1253/circj.70.1557, 17127799.
14. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112:1756-1762. 10.1161/CIRCULATIONAHA.104.530972, 16157772.
15. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, McMurray JJ. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007, 28:829-835. 10.1093/eurheartj/ehm033, 17403719.
16. Van Berendoncks AM, Garnier A, Beckers P, Hoymans VY, Possemiers N, Fortin D, Martinet W, Van Hoof V, Vrints CJ, Ventura-Clapier R, Conraads VM. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 2010, 3:185-194. 10.1161/CIRCHEARTFAILURE.109.885525, 20103776.
17. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, Shintani Y, Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H, Kitakaze M. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 2009, 53:2070-2077. 10.1016/j.jacc.2009.02.038, 19477358.
18. Park M, Sweeney G. Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail Rev 2012, . [Epub ahead of print].
19. Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, Marella GA, Colombi C, Foschini A, Valoti P, Mossello E, Fumagalli S, Marchionni N, Tarantini F. Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure. Nutr Metab Cardiovasc Dis 2012, 22:292-299. 10.1016/j.numecd.2011.03.012, 22032915.
20. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 33(Supp. 1):S62-S69. American Diabetes Association.
21. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6-min walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985, 132:919-923. 1345899, 3978515.
22. Picard MH, Adams D, Bierig SM, Dent JM, Douglas PS, Gillam LD, Keller AM, Malenka DJ, Masoudi FA, McCulloch M, Pellikka PA, Peters PJ, Stainback RF, Strachan GM, Zoghbi WA. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr 2011, 24:1-10. 10.1016/j.echo.2010.11.006, 21172594.
23. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, . ESC Committee for Practice Guidelines (CPG) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442. ESC Committee for Practice Guidelines (CPG).
24. Carlson KJ, Lee DC, Goroll AH, Leahy M, Johnson RA. An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis 1985, 38:733-739. 10.1016/0021-9681(85)90115-8, 4030999.
25. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 2009, 119:1977-2016.
26. Greenfield S, Blanco S, Elashoff RM, Ganz PA. Development and testing of a new index of comorbidity. Clin Res 1987, A35:346.
27. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17:37-49. 10.1016/0022-3956(82)90033-4, 7183759.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
29. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310. 10.1038/oby.2003.45, 12582228.
30. Chen WJY, Rijzewijk LJ, van der Meer RW, Heymans MW, van Duinkerken E, Lubberink M, Lammertsma AA, Lamb HJ, de Roos A, Romijn JA, Smit JWA, Bax JJ, Bjerre M, Frystyk J, Flyvbjerg A, Diamant M. Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. Cardiovasc Diabetol 2011, 10:67. 10.1186/1475-2840-10-67, 3157422, 21771299.
31. Birkenfeld AL, Boschmann M, Engeli S, Moro C, Arafat AM, Luft FC, Jordan J. Atrial natriuretic peptide and adiponectin interactions in man. PLoS One 2012, 7:e43238. 10.1371/journal.pone.0043238, 3420865, 22916229.
32. Won H, Kang SM, Shin MJ, Oh J, Hong N, Park S, Lee SH, Jang Y, Chung N. Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure. Yonsei Med J 2012, 53:91-98. 10.3349/ymj.2012.53.1.91, 3250329, 22187237.
33. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002, 106:3143-3421.
34. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, . for the Conference Participants Definition of metabolic syndrome. Report of the national heart, lung, and blood Institute/American heart association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958, for the Conference Participants.